"You're gonna need a bigger boat!" Today we discuss the third compound going to clinic emerging from Neil Camarta's "Shark Tank" meetings. This one from Satellos was designed to address the regeneration deficit in DMD caused by reduced asymmetric muscle stem cell division, and is now being repurposed for FSHD to potentially boost muscle regeneration regardless of DUX4 status.
Podden och tillhörande omslagsbild på den här sidan tillhör
Peter L Jones, PhD. Innehållet i podden är skapat av Peter L Jones, PhD och inte av,
eller tillsammans med, Poddtoppen.
